Trial · NCT03306043
Adverse events26
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 26
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Diarrhoea | Gastrointestinal disorders | Mepolizumab 300 mg SC | 12 | 102 | 13 |
| other | Vomiting | Gastrointestinal disorders | Mepolizumab 300 mg SC | 6 | 102 | 7 |
| other | Constipation | Gastrointestinal disorders | Mepolizumab 300 mg SC | 5 | 102 | 6 |
| other | Nausea | Gastrointestinal disorders | Mepolizumab 300 mg SC | 5 | 102 | 5 |
| other | Nasopharyngitis | Infections and infestations | Mepolizumab 300 mg SC | 5 | 102 | 5 |
| other | Bronchitis | Infections and infestations | Mepolizumab 300 mg SC | 4 | 102 | 4 |
| other | Sinusitis | Infections and infestations | Mepolizumab 300 mg SC | 4 | 102 | 4 |
| other | Upper respiratory tract infection | Infections and infestations | Mepolizumab 300 mg SC | 4 | 102 | 4 |
| other | Fatigue | General disorders | Mepolizumab 300 mg SC | 4 | 102 | 4 |
| other | Injection site reaction | General disorders | Mepolizumab 300 mg SC | 4 | 102 | 11 |
| other | Pruritus | Skin and subcutaneous tissue disorders | Mepolizumab 300 mg SC | 7 | 102 | 7 |
| other | Headache | Nervous system disorders | Mepolizumab 300 mg SC | 6 | 102 | 7 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Mepolizumab 300 mg SC | 5 | 102 | 6 |
| serious | Bacteraemia | Infections and infestations | Mepolizumab 300 mg SC | 1 | 102 | 1 |
| serious | Clostridium difficile colitis | Infections and infestations | Mepolizumab 300 mg SC | 1 | 102 | 1 |
| serious | Diverticulitis | Infections and infestations | Mepolizumab 300 mg SC | 1 | 102 | 1 |
| serious | Gastrointestinal infection | Infections and infestations | Mepolizumab 300 mg SC | 1 | 102 | 1 |
| serious | Infective exacerbation of bronchiectasis | Infections and infestations | Mepolizumab 300 mg SC | 1 | 102 | 1 |
| serious | Mycobacterium abscessus infection | Infections and infestations | Mepolizumab 300 mg SC | 1 | 102 | 1 |
| serious | Perihepatic abscess | Infections and infestations | Mepolizumab 300 mg SC | 1 | 102 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03306043/events